David Snyder
Director of Finance/CFO at COYA THERAPEUTICS, INC.
Net worth: 59 010 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Matthias G. Schroff | M | 56 |
Exicure Operating Co.
 Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | 6 years |
| Timothy Walbert | M | 57 |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | 5 years |
| Howard Berman | M | 50 | 4 years | |
| Bali Muralidhar | M | 44 |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | 5 years |
| Bosun Hau | M | 45 |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | 4 years |
| Jeffrey L. Cleland | M | 59 |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | 5 years |
| Hideki Garren | M | 60 | 3 years | |
| Chad A. Mirkin | M | 60 |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | 13 years |
| Fred Grossman | M | 62 | 1 years | |
| Christopher Kendrick-Parker | M | 59 | 16 years | |
| Dov Goldstein | M | 56 | 3 years | |
| Anna M Geyso | F | 60 | 13 years | |
| Ann Lee | M | 62 | 3 years | |
| Arun Swaminathan | M | - | 1 years | |
| Jeffrey Raizer | M | - |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | - |
| Jessica Starman | F | - | - | |
| Anabella Villalobos | M | 65 | 3 years | |
| Wilbur Ross | M | 85 | 1 years | |
| Michaelle Jean | F | 66 |
University of Ottawa
| 12 years |
| Dieter Weinand | M | 63 | 1 years | |
| John M. Centanni | M | - | 2 years | |
| Jay Venkatesan | M | 52 |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | 10 years |
| Helen Kim | F | 61 |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | 10 years |
| David Walt | M | 71 |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | 11 years |
| Michelle Frazier | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Elias D. Papadimas | M | 48 | 8 years | |
| Emile Nuwaysir | M | 55 | - | |
| Leonard J. Loventhal | M | 64 | 3 years | |
| Timothy D. Daley | M | 55 | - | |
| Michael van Handel | M | 64 | 5 years | |
| Stan Rose | M | 68 | 6 years | |
| Kenneth C. Hunt | M | 74 | 6 years | |
| Michael Edward Falk | M | 57 | 3 years | |
| Sheli Rosenberg | F | 82 | 2 years | |
| Colby Shad Thaxton | M | - | 8 years | |
| Adrian Hepner | M | 62 | 2 years | |
| Michelle Silva Wangham | M | 48 |
University of Ottawa
| 3 years |
| Weston Daniel | M | - | 3 years | |
| Christoph Jaeker | M | - | - | |
| Diego Garzón | M | - | - | |
| Suzie Cusson | F | - |
University of Ottawa
| 3 years |
| Madison Elkhazin | F | - |
University of Ottawa
| 4 years |
| Dhanbir Jaswal | M | 36 |
University of Ottawa
| 3 years |
| Alex Chevrette | M | - |
University of Ottawa
| 4 years |
| Jason Hunt | M | - |
University of Ottawa
| 5 years |
| Chi Le | F | - |
University of Ottawa
| 4 years |
| Stephen Kwai | M | - |
University of Ottawa
| 4 years |
| Fanny McKellips | F | - |
University of Ottawa
| 4 years |
| Mark Mannebach | M | - | - | |
| Jocelyn Trokenheim | F | - | 1 years | |
| Wen Bo Wang | M | - | - | |
| Gordon F. Beck | M | - |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | - |
| Thy Dinh | M | - |
University of Ottawa
| 8 years |
| Nabila Ali | F | 41 |
University of Ottawa
| 3 years |
| Douglas E. Feltner | M | 64 | 2 years | |
| Emil M. deGoma | M | - | - | |
| Ekambar R. Kandimalla | M | - | 4 years | |
| Gregory J. Lynch | M | 55 | 4 years | |
| Joseph Kipfer | M | - |
University of Ottawa
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 46 | 77.97% |
| Canada | 13 | 22.03% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David Snyder
- Personal Network
